IBM (NYSE:IBM) revealed on Thursday that it has signed an contract with the Lotte Group to provide cloud-based IBM Watson solutions to help the Group deliver innovation across the business and become a world-class retail company.Lotte Group represents the country’s largest retailer in a highly competitive retail market and is one of Korea’s top five companies, providing products and services to its consumers through online channels, mobile services and offline department stores, marts, convenience stores and duty-free shops.
Lotte Group will use Watson technologies to maximize insights from the huge amount of structured and unstructured consumer data collected through its various channels, including the Lotte Members program, deriving valuable learnings about consumer preferences and product feedback. With a deeper understanding of its data, Lotte will be enabled to offer more personalized services to consumers, consistent product information and expert advice tailored to individual consumer needs.
Antares Pharma, Inc. (NASDAQ:ATRS) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -3.90% to $2.22. Antares Pharma, Inc. (ATRS) reported that it had submitted a New Drug Application to the U.S. FDA for QuickShot Testosterone, a drug-device combination product for the delivery of testosterone enanthate using a subcutaneous auto injector.
QuickShot Testosterone is intended to treat adult men with low testosterone associated with a condition known as hypogonadism. The QuickShot auto injector is designed to allow rapid subcutaneous self-administration of highly viscous drugs such as testosterone and biologics using high spring pressure through a fine gauge needle. The QuickShot auto injector can also provide the patient with the ease and speed of self-administration, comfort and discretion. The share price of ATRS attracts active investors, as stock price of week volatility recorded 6.68%. The stock is going forward to its 52-week low with 231.34% and lagging behind from its 52-week high price with -8.26%.